Literature DB >> 11386612

Differential release of interleukines 6, 8, and 10 in cerebrospinal fluid and plasma after traumatic brain injury.

B Maier1, K Schwerdtfeger, A Mautes, M Holanda, M Müller, W I Steudel, I Marzi.   

Abstract

Traumatic brain injury (TBI) is characterized by a high mortality which is largely determined by the initial cerebral trauma, secondary brain injury or indirectly during a Multiple Organ Dysfunction Syndrome (MODS). Therefore, we analyzed IL-6, IL-8, and IL-10 in cerebrospinal fluid (CSF) and in plasma with respect to blood-brain barrier (BBB) integrity in 29 patients suffering from isolated TBI. IL-6 and IL-8 were significantly increased compared to baseline levels early after trauma in CSF and plasma. In all patients CSF IL-6 and IL-8 were found to be higher than corresponding plasma levels. IL-10 in plasma was significantly increased above control plasma values, however, without a significant difference to the corresponding CSF values. BBB dysfunction was temporary present in 23 patients. Significant correlations between BBB dysfunction and cytokines were not found. Thus, alterations of the BBB seems not to influence the distribution pattern of interleukines in CSF and plasma after trauma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11386612     DOI: 10.1097/00024382-200115060-00002

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  42 in total

Review 1.  How to Translate Time: The Temporal Aspects of Rodent and Human Pathobiological Processes in Traumatic Brain Injury.

Authors:  Denes V Agoston; Robert Vink; Adel Helmy; Mårten Risling; David Nelson; Mayumi Prins
Journal:  J Neurotrauma       Date:  2019-03-07       Impact factor: 5.269

Review 2.  What has inflammation to do with traumatic brain injury?

Authors:  David Cederberg; Peter Siesjö
Journal:  Childs Nerv Syst       Date:  2009-11-26       Impact factor: 1.475

Review 3.  The far-reaching scope of neuroinflammation after traumatic brain injury.

Authors:  Dennis W Simon; Mandy J McGeachy; Hülya Bayır; Robert S B Clark; David J Loane; Patrick M Kochanek
Journal:  Nat Rev Neurol       Date:  2017-02-10       Impact factor: 42.937

Review 4.  A Precision Medicine Approach to Cerebral Edema and Intracranial Hypertension after Severe Traumatic Brain Injury: Quo Vadis?

Authors:  Ruchira M Jha; Patrick M Kochanek
Journal:  Curr Neurol Neurosci Rep       Date:  2018-11-07       Impact factor: 5.081

Review 5.  Chemokine receptor CXCR2: physiology regulator and neuroinflammation controller?

Authors:  Mike Veenstra; Richard M Ransohoff
Journal:  J Neuroimmunol       Date:  2012-03-22       Impact factor: 3.478

6.  Biomarkers in polytrauma induced systemic inflammatory response syndrome and sepsis - a narrative review.

Authors:  Sebastian Daniel Trancă; Cristina Laura Petrişor; Natalia Hagău
Journal:  Rom J Anaesth Intensive Care       Date:  2014-10

7.  Immune activation promotes depression 1 month after diffuse brain injury: a role for primed microglia.

Authors:  Ashley M Fenn; John C Gensel; Yan Huang; Phillip G Popovich; Jonathan Lifshitz; Jonathan P Godbout
Journal:  Biol Psychiatry       Date:  2013-10-25       Impact factor: 13.382

8.  The Passage of S100B from Brain to Blood Is Not Specifically Related to the Blood-Brain Barrier Integrity.

Authors:  Andrea Kleindienst; Christian Schmidt; Hans Parsch; Irene Emtmann; Yu Xu; Michael Buchfelder
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-07-08

9.  Differential disruption of blood-brain barrier in severe traumatic brain injury.

Authors:  Melanie M Saw; Jenny Chamberlain; Michelle Barr; Matt P G Morgan; John R Burnett; Kwok M Ho
Journal:  Neurocrit Care       Date:  2014-04       Impact factor: 3.210

10.  Prehospital resuscitation with hypertonic saline-dextran modulates inflammatory, coagulation and endothelial activation marker profiles in severe traumatic brain injured patients.

Authors:  Shawn G Rhind; Naomi T Crnko; Andrew J Baker; Laurie J Morrison; Pang N Shek; Sandro Scarpelini; Sandro B Rizoli
Journal:  J Neuroinflammation       Date:  2010-01-18       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.